Verona Pharma plc (VRP.L) Share Forecast, Price & News

GBX 55
+3.00 (+5.77 %)
(As of 10/29/2020)
Today's Range
Now: GBX 55
50-Day Range
MA: GBX 30.45
52-Week Range
Now: GBX 55
Volume70,791 shs
Average Volume150,610 shs
Market Capitalization£228.00 million
P/E RatioN/A
Dividend YieldN/A
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.
Verona Pharma plc (VRP.L) logo

Industry, Sector and Symbol

Industry Biotechnology
Year FoundedN/A



Sales & Book Value

Annual SalesN/A
Cash FlowGBX 17 per share
Book ValueGBX 18 per share



Market Cap£228.00 million
Next Earnings DateN/A


Verona Pharma Plc to Host Earnings Call
February 25, 2021 |  finance.yahoo.com
Verona Pharma Plc Share Chat
December 30, 2020 |  lse.co.uk
Verona Pharma plc : Update on AIM Delisting
October 28, 2020 |  finance.yahoo.com
Verona (VRNA) Initiates Pivotal COPD Studies on Ensifentrine
September 25, 2020 |  finance.yahoo.com
Verona Pharma plc: Grant of RADSUs and PDMR Dealings
August 26, 2020 |  finance.yahoo.com
Shares in Verona Pharma outperform over three months
August 14, 2020 |  uk.finance.yahoo.com
Why Verona Pharma Stock Is Vaulting Higher Today
August 14, 2020 |  finance.yahoo.com
Benzinga's Top Upgrades, Downgrades For August 10, 2020
August 10, 2020 |  finance.yahoo.com
Top Ranked Momentum Stocks to Buy for August 6th
August 6, 2020 |  finance.yahoo.com
See More Headlines

GBX 55
+3.00 (+5.77 %)
(As of 10/29/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive VRP News and Ratings via Email

Sign-up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Verona Pharma plc (VRP.L) (LON:VRP) Frequently Asked Questions

Is Verona Pharma plc (VRP.L) a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verona Pharma plc (VRP.L) in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Verona Pharma plc (VRP.L) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VRP, but not buy additional shares or sell existing shares.
View analyst ratings for Verona Pharma plc (VRP.L)
or view top-rated stocks.

What stocks does MarketBeat like better than Verona Pharma plc (VRP.L)?

Wall Street analysts have given Verona Pharma plc (VRP.L) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Verona Pharma plc (VRP.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Verona Pharma plc (VRP.L)'s earnings last quarter?

Verona Pharma plc (VRP.L) (LON:VRP) announced its earnings results on Thursday, February, 27th. The company reported ($30.30) earnings per share for the quarter, topping the consensus estimate of ($30.80) by $0.50.
View Verona Pharma plc (VRP.L)'s earnings history

How has Verona Pharma plc (VRP.L)'s stock price been impacted by COVID-19?

Verona Pharma plc (VRP.L)'s stock was trading at GBX 49 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VRP shares have increased by 12.2% and is now trading at GBX 55.
View which stocks have been most impacted by COVID-19

Who are Verona Pharma plc (VRP.L)'s key executives?

Verona Pharma plc (VRP.L)'s management team includes the following people:
  • Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)
  • Mr. Piers John Morgan, Chief Financial Officer (Age 53)
  • Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)
  • Ms. Victoria Stewart, Director of Communications
  • Dr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57)

Who are some of Verona Pharma plc (VRP.L)'s key competitors?

What other stocks do shareholders of Verona Pharma plc (VRP.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Grifols (GRFS) and Innoviva (INVA).

What is Verona Pharma plc (VRP.L)'s stock symbol?

Verona Pharma plc (VRP.L) trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How do I buy shares of Verona Pharma plc (VRP.L)?

Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verona Pharma plc (VRP.L)'s stock price today?

One share of VRP stock can currently be purchased for approximately GBX 55.

How much money does Verona Pharma plc (VRP.L) make?

Verona Pharma plc (VRP.L) has a market capitalization of £228.00 million.

How many employees does Verona Pharma plc (VRP.L) have?

Verona Pharma plc (VRP.L) employs 22 workers across the globe.

What is Verona Pharma plc (VRP.L)'s official website?

The official website for Verona Pharma plc (VRP.L) is www.veronapharma.com.

Where are Verona Pharma plc (VRP.L)'s headquarters?

Verona Pharma plc (VRP.L) is headquartered at 3 More London Riverside, LONDON, SE1 2RE, United Kingdom.

How can I contact Verona Pharma plc (VRP.L)?

Verona Pharma plc (VRP.L)'s mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200.

This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.